- Home
- FGF vs IINN Comparison
FGF vs IINN Comparison
Compare FGF & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGF
- IINN
- Stock Information
- Founded
- FGF 2012
- IINN 2018
- Country
- FGF United States
- IINN Israel
- Employees
- FGF N/A
- IINN N/A
- Industry
- FGF Property-Casualty Insurers
- IINN Medical/Dental Instruments
- Sector
- FGF Finance
- IINN Health Care
- Exchange
- FGF Nasdaq
- IINN Nasdaq
- Market Cap
- FGF 28.0M
- IINN 25.9M
- IPO Year
- FGF N/A
- IINN 2021
- Fundamental
- Price
- FGF $22.01
- IINN $1.00
- Analyst Decision
- FGF
- IINN
- Analyst Count
- FGF 0
- IINN 0
- Target Price
- FGF N/A
- IINN N/A
- AVG Volume (30 Days)
- FGF 35.7K
- IINN 123.1K
- Earning Date
- FGF 11-14-2024
- IINN 08-15-2024
- Dividend Yield
- FGF N/A
- IINN N/A
- EPS Growth
- FGF N/A
- IINN N/A
- EPS
- FGF N/A
- IINN N/A
- Revenue
- FGF $22,351,000.00
- IINN N/A
- Revenue This Year
- FGF N/A
- IINN N/A
- Revenue Next Year
- FGF N/A
- IINN N/A
- P/E Ratio
- FGF N/A
- IINN N/A
- Revenue Growth
- FGF N/A
- IINN N/A
- 52 Week Low
- FGF $14.21
- IINN $0.76
- 52 Week High
- FGF $40.75
- IINN $2.49
- Technical
- Relative Strength Index (RSI)
- FGF 38.52
- IINN 19.59
- Support Level
- FGF $23.48
- IINN $1.32
- Resistance Level
- FGF $27.00
- IINN $1.28
- Average True Range (ATR)
- FGF 3.44
- IINN 0.06
- MACD
- FGF -1.21
- IINN -0.03
- Stochastic Oscillator
- FGF 1.32
- IINN 1.63
About FGF FG Financial Group Inc. (NV)
Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.